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TO THE EDITOR
In 2010, we identified a homozygous
nonsense mutation in the dystonin
(DST) gene in a Kuwaiti individual with
a new form of autosomal recessive epi-
dermolysis bullosa (EB) simplex (Groves
et al., 2010). The mutation occurred
within the coiled-coil rod domain of the
BPAG1-e isoform (the hemidesmo-
somal 230-kDa bullous pemphigoid
antigen) and the main symptom was
mild trauma-induced predominantly
acral blistering, although there was
also some generalized skin fragility.
However, additional neurological
features were noted, including episodes
of collapse, headaches, numbness,
and weakness. Molecular studies also
revealed a heterozygous mutation in
the NOTCH3 gene consistent with
concomitant autosomal dominant cere-
bral small-vessel arteriopathy (CADA-
SIL; MIM125310; Joutel et al., 1996).
Given that some DST isoforms may be
expressed in the central nervous system
(Young and Kothary, 2007; see Groves
et al., 2010, for details of alternative
splicing of DST), it was unclear whether
the overall clinical features were solely
due to the DST mutation or whether
NOTCH3 might be involved.
To address this further, we have now
identified a second unrelated family
with a different homozygous nonsense
mutation in the same region of the DST
gene. Notably, affected individuals have
mild skin blistering but no neuro-
logical abnormalities. The proband was
a 34-year-old Iranian woman who had
lifelong skin blistering that was worse
during summer. Blisters occurred on the
soles, at sites of friction from clothing,
and following removal of adhesive dress-
ings. The mouth, eyes, and genital areas
were never involved. No extracutaneous
symptoms were reported. Her father and
two of her three children also had mild
blistering. Blisters occurred on the feet
of her 15-year-old son following sporting
activities, and her 6-month-old son
developed blisters on the great toes after
starting to crawl; her husband reported
no skin fragility. Some consanguinity was
reported in the family, but precise details
were not forthcoming. On examination,
she had a solitary blister on the instep
of one foot (Figure 1a). The rest of her
skin appeared normal apart from subtle
atrophic scars affecting the shins, ankles,
elbows, dorsal aspects of the hands, and
lower back. Teeth, nails, and hair were
normal, and there was no palmoplantar
hyperkeratosis.
Following written and informed
consent, blood and skin samples were
obtained from the patient in adher-
ence to the Declaration of Helsinki
Principles. The skin sampled was
noninflamed and nonlesional. Initially,
we performed immunofluorescence
microscopy, as described elsewhere
(Groves et al., 2010). Labeling for
plectin, a6 and b4 integrin subunits,
keratin 14, laminin-332, and collagens
IV, VII, and XVII, however, showed
no abnormalities. Next, we undertook
transmission electron microscopy, as
described previously (Groves et al.,
2010). The morphology of individual
hemidesmosomes was abnormal with
poorly formed inner plaques, leading to
a lucent zone between keratin filaments
and outer hemidesmosomal plaques
(Figure 1b). The keratin filaments
extended to where the inner plaques
should be, but did not associate with
any attachment structures; no other
abnormalities were noted. Further skin
immunostaining with a mAb against
BPAG1-e (clone BPC319, directed
against the carboxyl terminus, Okumura
et al., 2002) showed a complete absence
of immunoreactivity compared with
bright, linear labeling at the dermal–
epidermal junction in control skin
(Figure 1c). Sequencing of the patient’s
genomic DNA identified a homo-
zygous A4T transversion (c.3853A4T;
GenBank NM_001723.4) that converts
arginine to a stop codon, designated
p.Arg1249X (Figure 1d). This mutation
occurs within the coiled-coil domain
in a region similar to the previously
reported DST mutation, p.Gln1124X
(Groves et al., 2010). The new mutation
was not identified in screening 200
ethnically matched control chromo-
somes. Sequencing of the genes encod-
ing keratins 5 and 14 revealed no
pathogenic mutations. Skin biopsies
and DNA samples were not available
from other family members, but the data
are consistent with autosomal recessive
EB simplex due to a homozygous loss-
of-function mutation in the DST gene
with a pseudodominant pattern of inheri-
tance in this consanguineous family.
The similar nature and sites of
the DST mutations in this and the
previously published case allow for
clinicopathological refinement of the
subtype of EB. BPAG1-e, or BP230, is a
structural component of hemidesmo-
somal inner plaques in basal keratino-
cytes (Guo et al., 1995; Yang et al.,
1996). The rod domain comprises a
coiled-coil region that is involved in
homodimerization, whereas the amino
terminus is important for the recruit-
ment of BPAG1-e into hemidesmo-
somes (Koster et al., 2003), and the
carboxy-terminal region binds to kera-
tin intermediate filaments (Yang et al.,
1996; Fontao et al., 2003). Loss-
of-function mutations in the coiled-coil
region in both cases led to similar
ultrastructural pathology with an
absence of hemidesmosomal inner
plaques and a ‘‘lucent zone’’ where
keratin filaments normally attach. Both
mutations also led to a complete
absence of BPAG1-e on skin immuno-
staining. However, skin immuno-
histochemistry in the Kuwaiti case also
reported abnormalities in labeling for
plectin, the b4 integrin subunit, and
collagen XVII—changes that were not
noted in the current case (data not
shown). These inconsistencies requireAbbreviations: DST, dystonin; EB, epidermolysis bullosa
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further assessment, including analysis
of the role of NOTCH3 in keratinocyte
cell biology (Michael et al., 2011).
Clinically, in the affected Iranian and
Kuwaiti subjects, there was genera-
lized skin fragility, but trauma-induced
blistering was greatest on the feet. Some
subtle and slightly atrophic scarring was
noted at sites of previous blistering in
the Iranian patient (this was the physi-
cal sign that prompted requesting a skin
biopsy), although only post-inflamma-
tory hyperpigmentation was noted in
the Kuwaiti. No nail dystrophy was
evident in the Iranian patient, and, in
addition, there was a clear exacer-
bation of blistering in hot weather, a
feature common to other forms of EB
simplex. Of significance, there were no
neurological symptoms or signs in the
Iranian individual, suggesting that in
the reported Kuwaiti subject the addi-
tional NOTCH3 gene pathology might
account for these features rather than
the DST mutation.
In summary, we have identified a
further case with mutations in the DST
gene resulting in autosomal recessive
EB simplex. The phenotype can resem-
ble autosomal dominant EB simplex,
but the clue to diagnosis lies in the lack
of hemidesmosomal inner plaques
on transmission electron microscopy.
This ultrastructural anomaly may also
be noted in other types of autosomal
recessive EB simplex, for example,
those resulting from PLEC1 mutations
(Smith et al., 1996), but additional
immunostaining of skin for BPAG1-e
establishes the precise diagnosis. The
clinicopathological findings attest to
the importance of BPAG1-e in hemi-
desmosome integrity and clarify the
nature of the skin fragility that ensues
from loss of its expression.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
Funding for this study was received from the
Dunhill Medical Trust and the Dystrophic Epider-
molysis Bullosa Research Association (DebRA,
UK). We also acknowledge financial support from
the UK Department of Health through the National
Institute for Health Research (NIHR) comprehen-
sive Biomedical Research Centre award to Guy’s &
St Thomas’ NHS Foundation Trust in partnership
with King’s College London and King’s College
Hospital NHS Foundation Trust.
Lu Liu1, Patricia J. Dopping-Hepenstal1,
Patricia A. Lovell1, Magdalene
Michael2, Helen Horn3, Kenneth
Fong2, Joey E. Lai-Cheong2,
Jemima E. Mellerio4, Maddy Parsons5
and John A. McGrath2
1The Robin Eady National Diagnostic
Epidermolysis Bullosa Laboratory, GSTS
Pathology, St Thomas’ Hospital, London, UK;
2St John’s Institute of Dermatology, King’s
College London, Guy’s Hospital, London, UK;
3Department of Dermatology, Royal Infirmary
of Edinburgh, Edinburgh, UK; 4St John’s
Institute of Dermatology, The Guy’s and
St Thomas’ NHS Foundation Trust, St Thomas’
Hospital, London, UK and 5Randall Division of
Cell and Molecular Biophysics, King’s College
London (Guy’s Campus), London, UK
E-mail: john.mcgrath@kcl.ac.uk
ControlPatient
ControlPatient
Control
T T T A A A AAC C CC G GT T T T A A A AAC C CC G GA
Patient
Figure 1. A homozygous nonsense mutation in the DST gene leads to lack of hemidesmosomal
inner plaques, an absence of BPAG1-e protein expression in skin, and autosomal recessive EB
simplex. (a) Clinically, there is a blister measuring 8 3 mm on the right foot instep (shown in higher
magnification on the right). (b) Transmission electron microscopy of the dermal–epidermal junction
(DEJ) in patient’s intact skin shows a lack of hemidesmosomal inner plaques (arrows) compared with
clearly discernible inner and outer plaques in control skin (bars¼ 100 nm). (c) Immunofluorescence
microscopy using a BPAG1-e antibody (clone BPC319) reveals completely undetectable immunostaining
at the DEJ in patient skin (arrows) in contrast to linear labeling at the DEJ in normal control skin
(bars¼ 50 mm). (d) DNA sequencing reveals a homozygous nonsense mutation in the DST gene
(c.3853A4T) that converts arginine to a stop codon (p.Arg1249X); this mutation occurs within the
coiled-coil rod domain of BPAG1-e. DST, dystonin; EB, epidermolysis bullosa.
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